In this episode of The Heart of Prevention, we zero in on the late-breaking clinical trials from ACC 2026 that are poised to shape the future of cardiovascular prevention.
Featuring trainees who attended the conference, we unpack the most practice-changing data across lipid management, cardiometabolic therapies, and risk reduction strategies. Our discussion highlights not just the results, but the clinical context—what these trials mean for patient care, where they challenge existing paradigms, and how they may influence guidelines moving forward.
From nuanced shifts in treatment thresholds to emerging therapies and implementation challenges, our trainee panel brings fresh, thoughtful perspectives from the frontlines of ACC. We also reflect on key themes across the late breakers, including personalization of prevention, residual risk, and advancing equity in cardiovascular care.
Whether you’re looking for a high-yield summary or deeper clinical insight, this episode delivers a focused, trainee-driven breakdown of the trials everyone is talking about.
Tune in for sharp analysis, practical takeaways, and what to watch next in prevention science.
","html":"","provider_name":"ART19","provider_url":"https://art19.com","title":"ACC 2026 Prevention Recap: Trainee Perspectives from the Frontlines","type":"rich","version":"1.0","width":720,"height":200}